Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Melasma Relapse During Summertime

NCT02061839 is registered in ClinicalTrials.gov with Centre de Pharmacologie Clinique Applique a la Dermatologie as lead sponsor.

NCT NCT02061839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02061839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Melasma Relapse During Summertime
Lead sponsor
Centre de Pharmacologie Clinique Applique a la Dermatologie
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2013
Completion date
October 31, 2013
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

melasma